143 related articles for article (PubMed ID: 7975222)
1. Psoralen treatment of adenovirus particles eliminates virus replication and transcription while maintaining the endosomolytic activity of the virus capsid.
Cotten M; Saltik M; Kursa M; Wagner E; Maass G; Birnstiel ML
Virology; 1994 Nov; 205(1):254-61. PubMed ID: 7975222
[TBL] [Abstract][Full Text] [Related]
2. Control of adenovirus packaging.
Ostapchuk P; Hearing P
J Cell Biochem; 2005 Sep; 96(1):25-35. PubMed ID: 15988756
[TBL] [Abstract][Full Text] [Related]
3. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
Ren S; Nassal M
J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
[TBL] [Abstract][Full Text] [Related]
5. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
[TBL] [Abstract][Full Text] [Related]
7. An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potent antitumoral efficacy but no toxicity to normal cell.
Tsukuda K; Wiewrodt R; Molnar-Kimber K; Jovanovic VP; Amin KM
Cancer Res; 2002 Jun; 62(12):3438-47. PubMed ID: 12067986
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation.
Schagen FH; Moor AC; Cheong SC; Cramer SJ; van Ormondt H; van der Eb AJ; Dubbelman TM; Hoeben RC
Gene Ther; 1999 May; 6(5):873-81. PubMed ID: 10505113
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus.
Jing XJ; Kalman-Maltese V; Cao X; Yang Q; Trempe JP
Virology; 2001 Dec; 291(1):140-51. PubMed ID: 11878883
[TBL] [Abstract][Full Text] [Related]
10. Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion.
Li J; Le L; Sibley DA; Mathis JM; Curiel DT
Virology; 2005 Aug; 338(2):247-58. PubMed ID: 15996701
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse.
Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO
Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942
[TBL] [Abstract][Full Text] [Related]
12. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production.
Aparicio O; Razquin N; Zaratiegui M; Narvaiza I; Fortes P
J Virol; 2006 Feb; 80(3):1376-84. PubMed ID: 16415015
[TBL] [Abstract][Full Text] [Related]
15. Recombinant equine arteritis virus as an expression vector.
de Vries AA; Glaser AL; Raamsman MJ; Rottier PJ
Virology; 2001 Jun; 284(2):259-76. PubMed ID: 11384225
[TBL] [Abstract][Full Text] [Related]
16. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
17. The role of the L4 33K gene in adenovirus infection.
Fessler SP; Young CS
Virology; 1999 Oct; 263(2):507-16. PubMed ID: 10544122
[TBL] [Abstract][Full Text] [Related]
18. [Expression of a gene encoding the porcine rotavirus VP7 capsid using a nondefective recombinant adenoviral genome].
Doronin KK; Iurov GK; Grinenko NF; Zakharchuk AN; Denisova TS; Baburina TM; Krugliak VA; Naroditskiĭ BS
Mol Gen Mikrobiol Virusol; 1995; (4):35-9. PubMed ID: 8604234
[TBL] [Abstract][Full Text] [Related]
19. Deletion analysis of four of eighteen late gene expression factor gene homologues of the baculovirus, BmNPV.
Gomi S; Zhou CE; Yih W; Majima K; Maeda S
Virology; 1997 Mar; 230(1):35-47. PubMed ID: 9126260
[TBL] [Abstract][Full Text] [Related]
20. Genome concatenation contributes to the late gene expression defect of an adenovirus E4 mutant.
Jayaram S; Bridge E
Virology; 2005 Nov; 342(2):286-96. PubMed ID: 16140353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
